ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB8 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CERS6 | Ceramide synthase 6 | Predicted membrane proteins
| | | | | Expressed in all |
EDNRB | Endothelin receptor type B | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ELOVL5 | ELOVL fatty acid elongase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
FZD10 | Frizzled family receptor 10 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR132 | G protein-coupled receptor 132 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
GPRC5A | G protein-coupled receptor, family C, group 5, member A | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPRC5B | G protein-coupled receptor, family C, group 5, member B | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HRH1 | Histamine receptor H1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
HTT | Huntingtin | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
KCNG1 | Potassium voltage-gated channel, subfamily G, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
LGR6 | Leucine-rich repeat containing G protein-coupled receptor 6 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MFSD2A | Major facilitator superfamily domain containing 2A | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MPDU1 | Mannose-P-dolichol utilization defect 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
NMBR | Neuromedin B receptor | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PARL | Presenilin associated, rhomboid-like | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
PHTF1 | Putative homeodomain transcription factor 1 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
PSEN2 | Presenilin 2 (Alzheimer disease 4) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PTAFR | Platelet-activating factor receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
RHBDL1 | Rhomboid, veinlet-like 1 (Drosophila) | Enzymes Predicted membrane proteins
| | | | | Mixed |
SLC15A3 | Solute carrier family 15 (oligopeptide transporter), member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC16A1 | Solute carrier family 16 (monocarboxylate transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC30A7 | Solute carrier family 30 (zinc transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
SLC35A2 | Solute carrier family 35 (UDP-galactose transporter), member A2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
TMEM115 | Transmembrane protein 115 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
TMEM164 | Transmembrane protein 164 | Predicted membrane proteins
| | | | | Expressed in all |
TMEM39A | Transmembrane protein 39A | Predicted membrane proteins
| | | | | Expressed in all |
TMEM87A | Transmembrane protein 87A | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TRPM4 | Transient receptor potential cation channel, subfamily M, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |